Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan

PloS One
Shian-Ying SungChia-Ling Hsieh

Abstract

Elevated Renal cell carcinoma (RCC) risk has been associated with the use of several antihypertensive medications but has not yet been elucidated in the populations prescribed alpha-1 blockers that are commonly used in the treatment of hypertension and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS-BPH). The aim of the present study was to investigate the association between alpha-1 blocker use and the risk of developing RCC using a nationwide population-based database in Taiwan. Patients who were treated with alpha-1 blockers for at least 28 days were identified through the Taiwan National Health Insurance Research Database from 2000 to 2010. The unexposed participants were matched with the exposed cases according to age, sex, and index year at a ratio of 3:1. Cox proportional hazards regression, stratified by sex and comorbidities and adjusted for age, was performed to estimate hazard ratios (HRs) for the risk of subsequent RCC. Among 2,232,092 subjects, patients who received alpha-1 blocker treatment had a higher risk of RCC than the unexposed group. Taking into account hypertension and BPH, the adjusted HR was significantly higher in male alpha-1 blocker users who had no BPH and either the p...Continue Reading

References

Sep 1, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·B Civantos Calzada, A Aleixandre de Artiñano
Sep 23, 2003·The Journal of Urology·Mark P CainRichard C Rink
Aug 7, 2004·Endocrinology·Pedro J Gonzalez-CabreraDianne M Perez
Nov 5, 2004·Journal of Cellular Biochemistry·Kaspar KeledjianNatasha Kyprianou
Apr 7, 2005·British Journal of Cancer·J P FryzekS Friis
Jul 7, 2007·Nature Clinical Practice. Urology·Karl-Erik Andersson, Christian Gratzke
Nov 1, 2007·Neoplasia : an International Journal for Oncology Research·Ssu-Chia LinJih-Hwa Guh
Dec 1, 2007·Urologic Oncology·Yun Hee YoumTag Keun Yoo
Feb 29, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Debra A Schwinn, Claus G Roehrborn
Mar 25, 2010·International Journal of Cancer. Journal International Du Cancer·Gary D FriedmanLaurel A Habel
Jan 29, 2011·European Urology·Shinichi SakamotoNatasha Kyprianou
Mar 23, 2011·The Journal of Urology·Kevin T McVaryJohn T Wei
Sep 2, 2011·Epidemiology·Joanne S ColtWong-Ho Chow
Apr 23, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Daisuke YamadaYukio Homma
Nov 16, 2013·Current Opinion in Urology·João SilvaFrancisco Cruz
Dec 17, 2014·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Osman Raif KarabacakMurat Alper
Feb 23, 2017·Cancer Causes & Control : CCC·Joanne S ColtMark P Purdue
Sep 24, 2018·European Urology·Umberto CapitanioPaul Russo
Jan 9, 2020·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.